- Home
- HTGC vs RYTM Comparison
HTGC vs RYTM Comparison
Compare HTGC & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTGC
- RYTM
- Stock Information
- Founded
- HTGC 2003
- RYTM 2008
- Country
- HTGC United States
- RYTM United States
- Employees
- HTGC N/A
- RYTM N/A
- Industry
- HTGC Investment Managers
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- HTGC Finance
- RYTM Health Care
- Exchange
- HTGC Nasdaq
- RYTM Nasdaq
- Market Cap
- HTGC 3.2B
- RYTM 3.1B
- IPO Year
- HTGC 2005
- RYTM 2017
- Fundamental
- Price
- HTGC $18.77
- RYTM $59.94
- Analyst Decision
- HTGC Buy
- RYTM Strong Buy
- Analyst Count
- HTGC 8
- RYTM 10
- Target Price
- HTGC $19.38
- RYTM $62.30
- AVG Volume (30 Days)
- HTGC 1.3M
- RYTM 700.5K
- Earning Date
- HTGC 10-30-2024
- RYTM 11-05-2024
- Dividend Yield
- HTGC 8.53%
- RYTM N/A
- EPS Growth
- HTGC 1.34
- RYTM N/A
- EPS
- HTGC 2.01
- RYTM N/A
- Revenue
- HTGC $494,410,000.00
- RYTM $112,530,000.00
- Revenue This Year
- HTGC $11.06
- RYTM $63.95
- Revenue Next Year
- HTGC $5.70
- RYTM $43.24
- P/E Ratio
- HTGC $9.33
- RYTM N/A
- Revenue Growth
- HTGC 12.81
- RYTM 81.55
- 52 Week Low
- HTGC $15.14
- RYTM $31.53
- 52 Week High
- HTGC $21.78
- RYTM $68.58
- Technical
- Relative Strength Index (RSI)
- HTGC 39.01
- RYTM 57.57
- Support Level
- HTGC $18.51
- RYTM $58.00
- Resistance Level
- HTGC $19.24
- RYTM $60.79
- Average True Range (ATR)
- HTGC 0.38
- RYTM 3.33
- MACD
- HTGC -0.09
- RYTM -0.29
- Stochastic Oscillator
- HTGC 16.45
- RYTM 46.42
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.